Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation

<div>Natural antibodies in patients not treated or treated with anti-rejection therapy (<i>n</i> = 110), treated with methylprednisolone alone (<i>n</i> = 15), or in combination with antithymocyte globulin (ATG) or alemtuzumab (<i>n</i> = 5) or intravenous immunoglobulin (IvIg) (<i>n</i> = 10) (a) and only in patients with late rejections (&gt;1 year after transplantation) (b).</div>

Journal of Transplantation

fig3

Figure 3

Figure 3: Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation 